HRT Financial’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,622
Closed -$475K 4208
2025
Q4
$475K Buy
+19,622
New +$476K ﹤0.01% 2135
2025
Q3
Sell
-9,510
Closed -$230K 3212
2025
Q2
$230K Sell
9,510
-98,047
-91% -$2.37M ﹤0.01% 2002
2025
Q1
$2.6M Buy
+107,557
New +$2.6M 0.02% 697
2024
Q4
Sell
-14,183
Closed -$344K 2770
2024
Q3
$344K Buy
+14,183
New +$341K ﹤0.01% 1748

Other funds holding IBDR

HRT Financial's IBDR Position: Q1 2026 in Review

HRT Financial sold out of iShares iBonds Dec 2026 Term Corporate ETF (IBDR) in Q1 2026, closing a stake of 19,622 shares — an estimated $475K sold.

HRT Financial first reported a position in IBDR in Q3 2024 and held it in 4 quarters. The position peaked at $2.6M in Q1 2025. 439 funds tracked by Wall St. Rank hold IBDR as of Q1 2026.

  • HRT Financial reported no remaining iShares iBonds Dec 2026 Term Corporate ETF position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 19,622 iShares iBonds Dec 2026 Term Corporate ETF shares in Q1 2026, an estimated $475K.
  • HRT Financial first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q3 2024 and held it in 4 quarters.
  • HRT Financial's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $2.6M in Q1 2025.
  • 439 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.